We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ENELAM:BCSEnel Americas S.A. Analysis

Data as of 2026-03-15 - not real-time

CLP 78.80

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Enel Américas trades at a trailing P/E of 9.5x, well below the industry average of 23x, and the DCF model indicates a potential upside of roughly 45%. The company delivered a 14% EBITDA increase and a 14.7% revenue growth year‑over‑year, underscoring solid top‑line momentum. While the dividend yield sits at 2.06% with an 80% payout ratio, free cash flow is currently negative, raising questions about long‑term sustainability. Technically, the stock sits just above its 20‑day SMA (78.8 vs 77.9) but below the 50‑day and 200‑day averages, with an RSI of 48 and a bullish MACD histogram, suggesting short‑term consolidation near the 73.95 support level and a near‑term resistance around 82.4. The utility sector’s regulated nature provides a defensive backdrop, yet exposure to multiple Latin‑American markets adds geographic and regulatory nuance. Overall, the blend of attractive valuation, earnings growth, and a modest dividend makes the stock appealing, but the bearish trend direction and liquidity‑driven volume decline warrant caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram indicating near‑term momentum
  • Price near support level with limited upside to resistance
  • Valuation still attractive relative to earnings

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue and EBITDA growth driven by renewable investments
  • Undervalued P/E versus industry peers
  • Attractive dividend yield despite payout concerns

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Diversified regulated utility footprint across several Latin‑American countries
  • Long‑term renewable capacity expansion (12.9 GW installed)
  • Stable cash‑flow profile offset by high debt levels

Key Metrics & Analysis

Financial Health

Revenue Growth14.70%
Profit Margin6.82%
P/E Ratio9.5
ROE7.69%
ROA4.47%
Debt/Equity38.70
P/B Ratio505.1
Op. Cash FlowCLP2.7B
Free Cash FlowCLP-1095807360
Industry P/E23.3

Technical Analysis

TrendBearish
RSI48.9
SupportCLP 73.95
ResistanceCLP 82.40
MA 20CLP 77.89
MA 50CLP 81.61
MA 200CLP 89.54
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueCLP 0.41
Target PriceCLP 114.74
Upside/Downside45.61%
GradeUndervalued
TypeBlend
Dividend Yield2.06%

Risk Assessment

Beta0.18
Volatility28.72%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.